Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Dec;49(4):588-94.
doi: 10.1111/j.1476-5381.1973.tb08534.x.

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice

G B Chesher et al. Br J Pharmacol. 1973 Dec.

Abstract

1. After oral administration to mice, pethidine, Delta(8)-tetrahydrocannabinol (THC), Delta(9)-THC, a cannabis extract and cannabinol had a dose-dependent antinociceptive effect when measured by the hot-plate method. Cannabidiol was inactive at 30 mg/kg. Delta(8)-THC, Delta(9)-THC and pethidine did not differ significantly in potency, but Delta(9)-THC was 6.5 times more active than cannabinol.2. After oral administration, three different cannabis extracts, Delta(8)-THC, Delta(9)-THC and morphine produced dose-dependent depressions of the passage of a charcoal meal in mice. Delta(8)-THC and Delta(9)-THC were equipotent and were about five times less potent than morphine. Cannabidiol was inactive up to 30 mg/kg. The effect of the three cannabis extracts on intestinal motility could be accounted for by their Delta(9)-THC content.3. The antinociceptive effect of pethidine and the effect of morphine on intestinal motility were antagonized by nalorphine whilst the effects of the cannabis extracts and the pure cannabinoids were not.4. From these results it is concluded that although cannabis and the narcotics share several common pharmacological properties, the mode of action of each is pharmacologically distinct.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Int Pharmacodyn Ther. 1968 Mar;172(1):24-31 - PubMed
    1. J Pharm Pharmacol. 1971 Apr;23(4):309-10 - PubMed
    1. Psychopharmacologia. 1971;22(2):187-94 - PubMed
    1. Arch Int Pharmacodyn Ther. 1972 Mar;196(1):133-45 - PubMed
    1. Psychopharmacologia. 1972;23(3):289-99 - PubMed

LinkOut - more resources